385 related articles for article (PubMed ID: 29040953)
21. Synthesis and antitumor activities of naturally occurring oleanolic acid triterpenoid saponins and their derivatives.
Liu Q; Liu H; Zhang L; Guo T; Wang P; Geng M; Li Y
Eur J Med Chem; 2013 Jun; 64():1-15. PubMed ID: 23639650
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antitumor activity evaluation of novel oleanolic acid derivatives.
Meng YQ; Zhao YW; Kuai ZY; Liu LW; Li W
J Asian Nat Prod Res; 2017 Oct; 19(10):1000-1010. PubMed ID: 28140665
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
[TBL] [Abstract][Full Text] [Related]
24. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
[TBL] [Abstract][Full Text] [Related]
25. [Synthesis and anti-tumor activity of oleanolic acid derivatives].
Meng YQ; Nie HH; Wang XC; Li D; Ge CX; Zhao N; Chen H; Cao B
Yao Xue Xue Bao; 2011 Oct; 46(10):1215-20. PubMed ID: 22242453
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
Huang G; Zhao HR; Meng QQ; Zhang QJ; Dong JY; Zhu BQ; Li SS
Eur J Med Chem; 2018 Jan; 143():166-181. PubMed ID: 29174813
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of triterpenoid thiazoles derived from betulonic acid, dihydrobetulonic acid, and ursonic acid.
Borková L; Frydrych I; Jakubcová N; Adámek R; Lišková B; Gurská S; Medvedíková M; Hajdúch M; Urban M
Eur J Med Chem; 2020 Jan; 185():111806. PubMed ID: 31677446
[TBL] [Abstract][Full Text] [Related]
28. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
[TBL] [Abstract][Full Text] [Related]
29. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
Wiemann J; Heller L; Csuk R
Bioorg Med Chem Lett; 2016 Feb; 26(3):907-909. PubMed ID: 26750249
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation.
Monika ; Sharma A; Suthar SK; Aggarwal V; Lee HB; Sharma M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3814-8. PubMed ID: 25027934
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vitro anticancer studies of novel C-2 arylidene congeners of lantadenes.
Tailor NK; Boon HL; Sharma M
Eur J Med Chem; 2013 Jun; 64():285-91. PubMed ID: 23644211
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of novel mitochondria-targeted CDDO derivatives as potential anti-cancer agents.
Ju W; Li N; Wang J; Yu N; Lei Z; Zhang L; Sun J; Chen L
Bioorg Chem; 2021 Oct; 115():105249. PubMed ID: 34390971
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Anticancer Activity of 3-(Substituted Aroyl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole Derivatives.
Zhan XP; Lan L; Wang S; Zhao K; Xin YX; Qi Q; Wang YL; Mao ZM
Chem Biodivers; 2017 Feb; 14(2):. PubMed ID: 27696660
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of diosgenin derivatives as apoptosis inducers through mitochondria-related pathways.
Ma L; Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
Eur J Med Chem; 2021 May; 217():113361. PubMed ID: 33740546
[TBL] [Abstract][Full Text] [Related]
35. Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
Rodríguez-Hernández D; Barbosa LCA; Demuner AJ; Nain-Perez A; Ferreira SR; Fujiwara RT; de Almeida RM; Heller L; Csuk R
Eur J Med Chem; 2017 Nov; 140():624-635. PubMed ID: 29024910
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of nitrogen-containing macrocyclic bisbibenzyl derivatives as potent anticancer agents by targeting the lysosome.
Sun B; Liu J; Gao Y; Zheng HB; Li L; Hu QW; Yuan HQ; Lou HX
Eur J Med Chem; 2017 Aug; 136():603-618. PubMed ID: 28570977
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK
Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and Evaluation of a Series of Oleanolic Acid Saponins as α-Glucosidase and α-Amylase Inhibitors.
Guo T; Wu S; Guo S; Bai L; Liu Q; Bai N
Arch Pharm (Weinheim); 2015 Sep; 348(9):615-28. PubMed ID: 26207761
[TBL] [Abstract][Full Text] [Related]
39. New perspective on the metabolism of AD-1 in vivo: Characterization of a series of dammarane-type derivatives with novel metabolic sites and anticancer mechanisms of active oleanane-type metabolites.
Ding M; Wang X; Zhang Y; Yuan W; Zhang H; Xu L; Wang Z; Lu J; Li W; Zhao Y
Bioorg Chem; 2019 Jul; 88():102961. PubMed ID: 31075741
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
